Effect of vaccination on the course of novel coronavirus infection in young patients

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The features of the course of the new coronavirus infection in vaccinated and unvaccinated young patients (aged 18–35 years) were assessed. In total, 111 patients with new coronavirus infection were examined, and they were divided into two groups. The first group included 32 people vaccinated against the new coronavirus infection (21 men and 11 women; average age, 22. 31 ± 5. 04 years), and the second group included 79 unvaccinated people (70 men and 9 women; average age, 20. 76 ± 3. 674 years). A direct dependence of hospitalization time on the presence of vaccination was observed. The average volume of erythrocytes was significantly greater in the vaccinated group than in the unvaccinated group, and the average concentration of hemoglobin in erythrocytes was higher in the unvaccinated group, both at disease onset and over time. In addition, in the vaccinated group, the values of inflammatory markers in the blood such as erythrocyte sedimentation rate, C-reactive protein, ferritin, procalcitonin, and D-dimer, increase much faster. According to the results of repeated computed tomography, the unvaccinated group had longer persistence of signs of viral pneumonia. The primary pathology recorded on the electrocardiogram, particularly bradycardia, was more frequently recorded in the unvaccinated group. Overall, most patients, regardless of vaccination, had a mild course of new coronavirus infection. This may indicate a negative dependence of the severity of the new coronavirus infection on the age of the patient. Despite the low risk of developing complications of coronavirus infection at a young age, to prevent and quickly recover from a new coronavirus infection, all age groups are encouraged to receive vaccination, which will reduce the number of hospitalizations, burden on healthcare, and economic costs of medical care.

Full Text

Restricted Access

About the authors

Renata R. Kalamova

Kirov Military Medical Academy

Author for correspondence.
Email: renata.kalamova@yandex.ru
ORCID iD: 0009-0000-9407-9511

cadet

Russian Federation, Saint Petersburg

Dmitry V. Cherkashin

Kirov Military Medical Academy

Email: cherkashin_dmitr@mail.ru
ORCID iD: 0000-0003-1363-6860
SPIN-code: 2781-9507

MD, Dr. Sci. (Med.), Professor

Russian Federation, Saint Petersburg

Victor A. Ulyatovsky

Kirov Military Medical Academy

Email: ulita1981@mail.ru
ORCID iD: 0009-0006-1905-1926
SPIN-code: 9217-8196

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Alexandra I. Zarubenko

Kirov Military Medical Academy

Email: alex.zarubenko@mail.ru
ORCID iD: 0009-0002-0758-4814
SPIN-code: 6662-0112

cadet

Russian Federation, Saint Petersburg

Islam S. Salakhbekov

Kirov Military Medical Academy

Email: salakhbekov1998@mail.ru
ORCID iD: 0009-0006-1001-9620
SPIN-code: 4680-0720

residency student

Russian Federation, Saint Petersburg

Vladimir Yu. Filippov

Kirov Military Medical Academy

Email: vladim-filippov@yandex.ru
ORCID iD: 0000-0001-7245-4683
SPIN-code: 6123-6576

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

Dmitriy S. Bogdanov

Kirov Military Medical Academy

Email: dimbog91@mail.ru
ORCID iD: 0000-0002-0939-7054
SPIN-code: 5070-8537

adjunct

Russian Federation, Saint Petersburg

Evgeny E. Voevodin

Kirov Military Medical Academy

Email: voevodinee@yandex.ru
ORCID iD: 0000-0001-9055-1321
SPIN-code: 4424-0962

MD, Cand. Sci. (Med.)

Russian Federation, Saint Petersburg

References

  1. Kucheruk TV, Novikova EN, Samartseva MO. Features of the course of the new coronavirus infection COVID-19 in vaccinated patients. Military Medical Journal. 2022;343(11):31–35. (In Russ.). doi: 10.52424/00269050_2022_343_11_31
  2. Kryukov EV, Trishkin DV, Salukhov VV, Ivchenko EV. Opyt voennoi meditsiny v bor’be s novoi koronavirusnoi infektsiei. Herald of the Russian Academy of Sciences. 2022;92(7):699–706. (In Russ.). doi: 10.31857/S086958732207009X
  3. Andreenko AA, Andreychuk YV, Arsentiev VG, et al. Infektsiya, vyzvannaya SARS-COV-2. Saint-Petersburg: VМА, 2023. 260 p.
  4. Gumilevsky BYu, Moskalev AV, Apchel VYa, Tsygan VN. Old new coronavirus. Bulletin of the Russian Military Medical Academy. 2020;22(2):182–188. (In Russ.). doi: 10.17816/brmma50070
  5. Gumilevsky BYu, Moskalev AV, Gumilevskaya OP, et al. Features of immunopathogenesis of a new coronavirus infection. Bulletin of the Russian Military Medical Academy. 2021;23(1):187–198. (In Russ.). doi: 10.17816/brmma.63654
  6. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA. 2020;180(7): 934–943. doi: 10.1001/jamainternmed.2020.0994
  7. Vechorko VI, Evsikov EM, Baykova OA, Levchuk NN. Character of hematological parameters change in patients with covid-19. The Russian Journal of Preventive Medicine. 2020;23(8):57–63. (In Russ.). doi: 10.17116/profmed20202308157
  8. Jiaming L, Yanfeng Y, Yao D, et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine. 2017;35(1):10–18. doi: 10.1016/j.vaccine.2016.11.06454
  9. Huang W, Berube J, McNamara M, et al. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry Part A. 2020;97(8):772–776. doi: 10.1002/cyto.a.24172
  10. Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ. 2021;26(3):107–108. doi: 10.1136/bmjebm-2020-111536
  11. Linets Yu P, Artyukhov SV, Kazantsev AN, et al. The course of COVID-19 in vaccinated patients. Russian Sklifosovsky Journal “Emergency Medical Care. 2021;10(4):636–641. doi: 10.23934/2223-9022-2021-10-4-636-641
  12. Douedi S, Mararenko A, Alshami A, et al. COVID-19 induced bradyarrhythmia and relative bradycardia: An overview. J Arrhythm. 2021;37(4):888–892. doi: 10.1002/joa3.12578
  13. Amaratunga EA, Corwin DS, Moran L, Snyder R. Bradycardia in Patients With COVID-19: A Calm Before the Storm? Cureus. 2020;12(6):e8599. doi: 10.7759/cureus.8599
  14. Grebennikova IV, Lidokhova OV, Makeeva AV, et al. Hematological indices in COVID-19: a retrospective study. Journal of New Medical Technologies. 2022;16(6):87–91. (In Russ.). doi: 10.24412/2075-4094-2022-6-3-5
  15. Kryukov EV, Trishkin DV, Ivanov AM, et al. Comparative cohort epidemiological study of collective immunity against new coronavirus infection among different groups of military personnel. Annals of the Russian Academy of Medical Sciences. 2021;76(6):661–668. (In Russ.). doi: 10.15690/vramn1583

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77762 от 10.02.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies